Outcomes of relapsed favorable‐histology Wilms tumor in non‐clinical trial setting
Outcomes for all strata of relapsed WT patients treated in a non-clinical setting appear to have similar outcomes to historical cohorts treated on NWTS-5. Improved strategies are urgently needed for HRR and VHRR relapses.
Authors
- Conrad V. Fernandez (ORCID: https://orcid.org/0000-0002-0746-8306)
- Kylene DeSmith
- Cameron O'Connell
- Elizabeth Anne Mullen (ORCID: https://orcid.org/0000-0002-6704-0002)
- Rajkumar Venkatramani (ORCID: https://orcid.org/0000-0002-4785-106X)
- Netta Schneller (ORCID: https://orcid.org/0000-0001-7299-3986)
- Leo Mascarenhas (ORCID: https://orcid.org/0000-0001-7790-0777)
- Whitney Throckmorton
- Kathryn S. Sutton (ORCID: https://orcid.org/0000-0002-6451-6589)
- Najat C. Daw (ORCID: https://orcid.org/0000-0002-6941-8005)
Institutions
- University of Southern California (US)
- Dalhousie University (CA)
- Children's Hospital of Los Angeles (US)
- The University of Texas MD Anderson Cancer Center (US)
- Emory University (US)
- Baylor College of Medicine (US)
- Izaak Walton Killam Health Centre (CA)
- Aflac (United States) (US)
- Dana-Farber Cancer Institute (US)
- Children's Healthcare of Atlanta (US)
- Children's Cancer Center (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2024-10-12
- DOI
- https://doi.org/10.1002/pbc.31347
- Citations
- 1
- Primary Topic
- Renal and related cancers
- Type
- article
- Field-Weighted Citation Impact
- 0.23